Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-24 @ 10:37 PM
NCT ID:
NCT05116735
Eligibility Criteria:
Inclusion Criteria:
* Stages CE2
* CE3b According to the WHO-IWGE classification
* solitary
* symptomatic or asymptomatic
* superficial cyst
* cases not suited for hepatic resection as the cyst wall abutting critical vascular and biliary structures as hepatic resection is harmful or excessive loss of hepatic tissue
Exclusion Criteria:
* stages CL, CE1, CE3a, CE4, CE5 according to WHO-IWGE classification of the hydatid cyst
* preoperative total bilirubin level greater than 2.0 mg/dl and direct bilirubin level greater than 1.5 mg/dl
* common bile duct dilatation greater than 10 mm , or CT, or MRI, previous percutaneous treatment
* recurrent cases after any type of surgery, cases with associated extrahepatic or extra-abdominal hydatid cyst
* cysts affecting an entire lobe or the main pedicles
* stages Cysts that are complicated (ruptured or diseased cysts), deep cysts .Patients who refuse intervention, have a surgical contraindication, are pregnant, have hydatid cysts in both lobes of the liver, previous liver surgery, liver abscess, frank CBC, cases lost during follow-up, cases who refused to take albendazole, or cases who developed albendazole-related issues (disturbed liver function).
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05116735
Study Brief:
Protocol Section:
NCT05116735